NeuroOne Medical Technologies CorporationNMTCNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P14
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-6.55%
202414.08%
2023-0.76%
202211.49%
202131.71%
202010.94%
201921.07%
201851.42%
20177066.26%
20165.49%